Diabetes and respiratory diseases as comorbid conditions in COVID-19 patients from Kazakhstan: a retrospective pilot study
PeerJ · 2025
DOI: 10.7717/peerj.20413 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Karlygash Tazhibayeva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Al-Farabi Kazakh National University, Almaty, Kazakhstan. Hauptthemen laut MEDLINE: COVID-19, Diabetes Mellitus. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Diabetes and respiratory diseases are prevalent in Central Asia, and their prevention represents an opportunity to increase life expectancy in the region, especially in Kazakhstan. This study aims to analyze trends in the prevalence of diabetes and respiratory diseases as comorbidities in patients with recent COVID-19 infections, based on the information obtained from several clinics in Almaty, Kazakhstan.
Methods
This study was conducted as a cross-sectional analysis using de-identified electronic medical records from a multidisciplinary hospital in Almaty, Kazakhstan. Adults hospitalized with laboratory-confirmed COVID-19 during 2021–2022 were included ( N = 292; mean age 55 years, range 18–91). Continuous variables were summarized with means and standard deviations, and categorical variables with counts and percentages. Data extraction and statistical analyses were performed in September–December 2023.
Results
The mortality rate was higher among patients with pneumonia (16.8%) compared to chronic bronchitis (10.6%). We identified a high level of comorbidity with diabetes (35.3% in the 45–59 age group) and chronic respiratory disease (37.9% in the same group).
Discussion
The mortality and comorbidity rates for hospitalized patients with recent COVID-19 infections in Almaty were high in comparison to other middle-income countries. These findings underscore the need for targeted early prevention strategies and public health interventions to address the rising burden of chronic diseases in Kazakhstan, particularly among middle-aged adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Al-Farabi Kazakh National University, Almaty, Kazakhstan.
- Duquesne University, Pittsburgh, PA, United States of America.
- Kazakh National Medical University Named After S. D. Asfendiyarov, Almaty, Kazakhstan.
Zitieren
APA
Tazhibayeva, K., Abdrakhmanova, Z., Shensa, A., Raushanova, A., Sadykova, A., Glushkova, N., Mamyrbekova, S., Zhagiparova, Z., Beisbekova, A., & Linkov, F. (2025). Diabetes and respiratory diseases as comorbid conditions in COVID-19 patients from Kazakhstan: a retrospective pilot study. PeerJ. https://doi.org/10.7717/peerj.20413
Vancouver
Tazhibayeva K, Abdrakhmanova Z, Shensa A, Raushanova A, Sadykova A, Glushkova N, et al. Diabetes and respiratory diseases as comorbid conditions in COVID-19 patients from Kazakhstan: a retrospective pilot study. PeerJ. 2025. doi:10.7717/peerj.20413
BibTeX
@article{Tazhibayeva2025,
author = {Tazhibayeva, Karlygash and Abdrakhmanova, Zinat and Shensa, Ariel and Raushanova, Aizhan and Sadykova, Assel and Glushkova, Natalya and Mamyrbekova, Saltanat and Zhagiparova, Zhanar and Beisbekova, Arailym and Linkov, Faina},
title = {Diabetes and respiratory diseases as comorbid conditions in COVID-19 patients from Kazakhstan: a retrospective pilot study},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.20413}
}
EUVIMED